Index Fund Advisors’s AbbVie ABBV Stock Holding History

Index Fund Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.19M	Sell	4,716 -3	-0.1%	-$645	0.05%	64
2026 Q1	$1.03M	Buy	+4,719	New	+$1.05M	0.05%	64
2025 Q2	–	Sell	-1,082	Closed	-$227K	–	145
2025 Q1	$227K	Sell	1,082 -322	-23%	-$62.6K	0.01%	90
2024 Q4	$250K	Sell	1,404 -30	-2%	-$5.52K	0.01%	95
2024 Q3	$283K	Buy	+1,434	New	+$268K	0.02%	84
2022 Q4	–	Sell	-5,045	Closed	-$677K	–	80
2022 Q3	$677K	Buy	5,045 +400	+9%	+$57.4K	0.05%	39
2022 Q2	$711K	Buy	4,645 +350	+8%	+$53.5K	0.05%	40
2022 Q1	$696K	Sell	4,295 -660	-13%	-$95.9K	0.05%	42
2021 Q4	$671K	Buy	+4,955	New	+$585K	0.05%	49

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Index Fund Advisors's ABBV Position: Q2 2026 in Review

Index Fund Advisors reduced its AbbVie (ABBV) stake by 0.06% in Q2 2026, selling an estimated $645 and leaving 4,716 shares worth $1.19M. The position accounts for 0.05% of the portfolio, ranked #64.

Index Fund Advisors first reported a position in ABBV in Q4 2021 and has held it in 9 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Index Fund Advisors held 4,716 shares of AbbVie worth $1.19M as of Q2 2026.
Index Fund Advisors sold 3 AbbVie shares in Q2 2026, an estimated $645.
AbbVie made up 0.05% of Index Fund Advisors's portfolio in Q2 2026, its #64 holding.
Index Fund Advisors first reported a position in AbbVie in Q4 2021 and has held it in 9 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Index Fund Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.